Literature DB >> 1452662

Establishment of a particle-counting method for purified elementary bodies of chlamydiae and evaluation of sensitivities of the IDEIA Chlamydia kit and DNA probe by using the purified elementary bodies.

N Miyashita1, A Matsumoto.   

Abstract

To evaluate the sensitivity of commercially available test kits for detection of chlamydiae, we established a method of purifying Chlamydia trachomatis and Chlamydia pneumoniae elementary bodies (EBs). We then subjected the purified EBs, together with the purified EBs of Chlamydia psittaci, to the IDEIA Chlamydia (IDEIA) and DNA probe test kits to determine the EB numbers at the detection limits. The sensitivities of the test kits were thus compared. The results can be summarized as follows. (i) Intact EBs in the purified preparations were present at 100, 96.3, and 97% for the C. psittaci Cal 10, C. trachomatis L2/434/Bu (L2), and C. pneumoniae TW-183 strains, respectively. The preparations of the L2 and TW-183 EBs contained a few EB envelopes, which reacted with antilipopolysaccharide monoclonal antibodies, as did the intact EBs, indicating that elimination of EB envelopes is not required for testing of the IDEIA kit's sensitivity. (ii) We established a method of counting intact EBs and EB envelopes under a scanning electron microscope after sedimentation of EBs on a coverslip by centrifugation. (iii) The EB numbers per assay at the cutoff level, which is set up in the IDEIA kit, were 9.6 x 10(2), 6.5 x 10(3), and 2.5 x 10(4) for the L2, TW-183, and Cal 10 strains, respectively. When the same EB preparations were applied to the DNA probe kit, the EB number at the cutoff level was 7.5 x 10(3) per assay for the L2 strain, but no reaction occurred for the Cal 10 and TW-183 strains at any EB number, indicating that the DNA probe kit is highly specific for C. trachomatis. Although the IDEIA kit designed for detection of C. trachomatis showed a sensitivity superior to that of the DNA probe, the chlamydial species was not determined by the IDEIA kit.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1452662      PMCID: PMC270551          DOI: 10.1128/jcm.30.11.2911-2916.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  PURIFICATION AND CHEMICAL COMPOSITION OF MENINGOPNEUMONITIS VIRUS.

Authors:  A TAMURA; N HIGASHI
Journal:  Virology       Date:  1963-08       Impact factor: 3.616

2.  RNA SYNTHESIS IN CELLS INFECTED WITH THE MENINGOPNEUMONITIS AGENT.

Authors:  A TAMURA; M IWANAGA
Journal:  J Mol Biol       Date:  1965-01       Impact factor: 5.469

3.  Evaluation of three Chlamydia trachomatis immunoassays with an unbiased, noninvasive clinical sample.

Authors:  I D Paul; E O Caul
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

4.  Primary isolation of TRIC organisms in HeLa 229 cells treated with DEAE-dextran.

Authors:  C Kuo; S Wang; B B Wentworth; J T Grayston
Journal:  J Infect Dis       Date:  1972-06       Impact factor: 5.226

5.  Purification and chemical composition of reticulate bodies of the meningopneumonitis organisms.

Authors:  A Tamura; A Matsumoto; N Higashi
Journal:  J Bacteriol       Date:  1967-06       Impact factor: 3.490

6.  Molecular techniques for the detection of Chlamydia trachomatis.

Authors:  E M Peterson; R Oda; R Alexander; J R Greenwood; L M de la Maza
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

7.  Evaluation of a nonisotopic probe for detection of Chlamydia trachomatis in endocervical specimens.

Authors:  G L Woods; A Young; J C Scott; T M Blair; A M Johnson
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

8.  Monoclonal antibody against a genus-specific antigen of Chlamydia species: location of the epitope on chlamydial lipopolysaccharide.

Authors:  H D Caldwell; P J Hitchcock
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

Review 9.  Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases.

Authors:  J T Grayston; S P Wang; C C Kuo; L A Campbell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-03       Impact factor: 3.267

10.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.

Authors:  J T Grayston; C C Kuo; S P Wang; J Altman
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

View more
  11 in total

1.  Seroepidemiology of Chlamydia pneumoniae in Japan between 1991 and 2000.

Authors:  N Miyashita; H Fukano; K Yoshida; Y Niki; T Matsushima
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

2.  Development and evaluation of a loop-mediated isothermal amplification method for the rapid detection of Chlamydophila pneumoniae.

Authors:  Y Kawai; N Miyashita; F Kishi; M Tabuchi; K Oda; T Yamaguchi; K Kawasaki; T Yamazaki; K Ouchi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-11       Impact factor: 3.267

3.  Chlamydia DNA extraction for use in PCR: stability and sensitivity in detection.

Authors:  H Daugharty; S K Skelton; T Messmer
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

4.  Evaluation of the sensitivity and specificity of a ligase chain reaction test kit for the detection of Chlamydia trachomatis.

Authors:  N Miyashita; A Matsumoto; Y Niki; T Matsushima
Journal:  J Clin Pathol       Date:  1996-06       Impact factor: 3.411

5.  Plaque formation by and plaque cloning of Chlamydia trachomatis biovar trachoma.

Authors:  A Matsumoto; H Izutsu; N Miyashita; M Ohuchi
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

6.  Chlamydia pneumoniae infects and multiplies in lymphocytes in vitro.

Authors:  S Haranaga; H Yamaguchi; H Friedman; S Izumi; Y Yamamoto
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

7.  Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.

Authors:  Margaret M Madeleine; Tarja Anttila; Stephen M Schwartz; Pekka Saikku; Maija Leinonen; Joseph J Carter; Michelle Wurscher; Lisa G Johnson; Denise A Galloway; Janet R Daling
Journal:  Int J Cancer       Date:  2007-02-01       Impact factor: 7.396

Review 8.  Diagnosis and assessment of trachoma.

Authors:  Anthony W Solomon; Rosanna W Peeling; Allen Foster; David C W Mabey
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Characterization of Chlamydia pneumoniae species-specific proteins immunodominant in humans.

Authors:  Y Iijima; N Miyashita; T Kishimoto; Y Kanamoto; R Soejima; A Matsumoto
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

10.  Sensitivities of PCR, MicroTrak, ChlamydiaEIA, IDEIA, and PACE 2 for purified Chlamydia trachomatis elementary bodies in urine, peripheral blood, peripheral blood leukocytes, and synovial fluid.

Authors:  J G Kuipers; K Scharmann; J Wollenhaupt; E Nettelnbreker; S Hopf; H Zeidler
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.